Skip to main content
. 2016 Dec 14;5:1900110. doi: 10.1109/JTEHM.2016.2639481

TABLE 1. Measurement and Subject Characteristics.

Training Data Testing Data
Cohort 1 Cohort 2 Cohort 1 Cohort 2 Cohort 3
Measurement Characteristics
Device Omron Microlife Omron Microlife Microlife
Reference Invasive Invasive Invasive Invasive Auscultation
# of Subjects 20 37 58 11 19
# of Baseline Measurements 20 37 36 11 19
# of Nitroglycerin Measurements 8 36 32 11 0
# of Repeated Measurements 0 73 0 16 16
Total # of Measurements 28 146 68 38 35
Subject Characteristics
Type Cardiac Catheterization Normal
Age [years] 65.1±15.4 65.2±12.3 59.8±15.0 69.0±12.4 34.0±9.4
Weight [kg] 64.5±12.4 74.6±13.4 70.12±11.5 68.9±14.2 60.4±15.8
Height [cm] 164.0±6.4 163.6±8.0 161.6±7.8 162.2±10.4 164.2±9.3
Waist circumference [cm] 84.6±11.4 90.0±12.3 91.8±9.5 97.2±11.9 75.8±11.2
Men [%] 85 75.7 74.1 72.7 36.8
Smoking [%] 35 18.9 20.7 27.3 N/A
Clinical diagnosis [%]
Hypertension 65 59.5 56.9 90.9 N/A
Type 2 Diabetes Mellitus 20 29.7 31 54.5 N/A
Dyslipidemia 45 37.8 41.4 36.4 N/A
Coronary Artery Disease 40 59.5 56.9 63.6 N/A
Chronic Renal Failure 5 2.7 3.4 18.2 N/A
Medications [%]
Inline graphicBlockers 20 13.5 12.1 27.3 N/A
Inline graphicBlockers 30 43.2 37.9 63.6 N/A
Calcium Channel Blockers 25 48.6 41.4 27.3 N/A
Diuretics 20 18.9 20.7 36.4 N/A
Antiplatelet Agents 65 86.5 70.7 81.8 N/A